<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04199208</url>
  </required_header>
  <id_info>
    <org_study_id>PRIO01</org_study_id>
    <nct_id>NCT04199208</nct_id>
  </id_info>
  <brief_title>Does Prehabilitation Improve Outcome in Coloncancer Surgery?</brief_title>
  <acronym>PRIO</acronym>
  <official_title>The Effect of Prehabilitation on Surgical Complications Following Colon Surgery - a Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to find out if complications after surgery for large bowel (colon) cancer can
      be reduced or avoided in the most frail and elderly by letting them go through an exercise-
      and diet regime prior to the surgical procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients with colon cancer who are intended for curative surgery without neoadjuvant
      chemotherapy who are &gt;=60 years old will be screened with an ergospirometry. The ones that
      have a ventilate anaerobic threshold (VAT) of less than 11 mg/ml/kg will be included in the
      study as they are considered extra frail and have a previously proven high risk for
      complications. These patients will be randomized to standard care or an intervention of
      prehabilitation consisting of immunonutrition (protein supplement, multivitamin supplement,
      Selene etc) and an exercise regimen with 4x1 hours per week of cycling on an ergometer. The
      exercise regimen will be performed in a group of patients and will be led by a physical
      therapist to ensure compliance. The resistance of the ergometer will be standardized
      according to the patient's VAT.

      The primary outcome measures will be number of and severity of postoperative complications.
      Secondary outcome measures include quality of life during prehabilitation with repeated
      measurements during 5 years after surgery, disease-free survival and overall survival.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">January 7, 2028</completion_date>
  <primary_completion_date type="Anticipated">January 7, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized two-armed clinical trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>Assessed when patient is discharged from hospital</time_frame>
    <description>Severity of postoperative complications according do Clavien-Dindo</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>Assessed at postoperative day 5.</time_frame>
    <description>Number of complication(s) according to POMS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life with SF-36</measure>
    <time_frame>At point in time when patient is informed of the cancer, after prehabilitation (just before surgery), 30 days, 2, 3 and 6 months, 1, 3 and 5 years after surgery.</time_frame>
    <description>Quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>30 and 90 days after surgery, 1, 3 and 5 years after surgery.</time_frame>
    <description>Cancer-free survival Cancer-free survival of the group of the group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>30 and 90 days after surgery, 1, 3 and 5 years after surgery.</time_frame>
    <description>Overall survival of the group (taking all causes of death into account)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Surgery--Complications</condition>
  <arm_group>
    <arm_group_label>Standard Care Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard perioperative care is given.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interventional Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention of prehabilitation and immunonutrition is given prior to surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prehabilitation and Immunonutrition</intervention_name>
    <description>See study synopsis</description>
    <arm_group_label>Interventional Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Care Arm</intervention_name>
    <description>Standard care as per the daily routines of the Hospital at which the study takes place</description>
    <arm_group_label>Standard Care Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 years of older

          -  Colon cancer diagnosis (macroscopic, microscopic or x-ray diagnosed)

          -  Ventilatory Anaerobic Threshold &lt;11mg/ml/kg

          -  Planned open or laparoscopic colectomy due to colon cancer

        Exclusion Criteria:

          -  Lower extremity amputee

          -  Disease requiring radio- and/or chemotherapy prior to surgery/palliative disease

          -  Distal metastases (Locoregional lymph nodes are OK)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Öberg, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Skåne/Lund University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Öberg, MD, PhD</last_name>
    <phone>+46424061000</phone>
    <email>stefan.oberg@med.lu.se</email>
  </overall_contact>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>exercise therapy</keyword>
  <keyword>perioperative period</keyword>
  <keyword>coloncancer</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 10, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/08/NCT04199208/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

